Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-15

Clinical Trial Update: A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety, tolerability, and effectiveness of Recifercept in children with Achondroplasia; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recifercept

Snippet

Sponsor: Pfizer | Conditions: Achondroplasia | Phase 2 | Status: TERMINATED | Results posted: 2024-02-15